Key Insights

Highlights

Treatment Research

3 treatments under study, led by Ip 1 Membrane Wrap Hydro

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Not Yet Recruiting1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07701590Not ApplicableRecruiting

CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

NCT07647705Not ApplicableNot Yet Recruiting

Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU)

Showing all 2 trials

Research Network

Common Treatments

  • Ip 1 Membrane Wrap Hydro1
  • Borate Based Bioactive Glass Fiber Matrix Bbgfm1
  • Microlyte1

Active Sponsors

  • Capsicure, LLC1
  • BioLab Holdings1
  • ETS Wound Care, LLC1

Top Investigators

Related Conditions

  • Venus Leg Ulcer Vlu1
  • Venus Ulcer1
  • Wound Foot1
  • Vlu1
  • Diabetic Foot Ulcer Dfu1

Activity Timeline